Purification of 5'-nucleotidase from human placenta after release from plasma membranes by phosphatidylinositol-specific phospholipase C

Biochem Biophys Res Commun. 1987 May 29;145(1):118-25. doi: 10.1016/0006-291x(87)91295-2.

Abstract

5'-Nucleotidase was purified greater than 1000-fold from human placenta by treatment of plasma membranes with S. aureus phosphatidylinositol-specific phospholipase C and affinity chromatography on Con A Sepharose and AMP-Sepharose. The resulting enzyme had a specific activity of greater than 5000 mumol/hr/mg protein and a subunit molecular weight of 73,000. Goat antibodies against 5'-nucleotidase inhibited enzyme activity and detected 5'-nucleotidase after Western blotting. These antibodies also recognized a soluble form of 5'-nucleotidase and residual membrane-bound 5'-nucleotidase which could not be released by phosphatidylinositol-specific phospholipase C treatment, suggesting that the three forms of the enzyme are structurally related. The soluble 5'-nucleotidase may be derived from the membrane-bound form by the action of an endogenous phospholipase C. The structural basis for the inability of some of the membrane-bound 5'-nucleotidase to be released by phosphatidylinositol-specific phospholipase C is unknown.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 5'-Nucleotidase
  • B-Lymphocytes / enzymology
  • Cell Membrane / enzymology
  • Chromatography, Affinity / methods
  • Female
  • Humans
  • Molecular Weight
  • Nucleotidases / isolation & purification*
  • Nucleotidases / metabolism
  • Phosphatidylinositols / metabolism
  • Placenta / enzymology*
  • T-Lymphocytes / enzymology
  • Type C Phospholipases / metabolism*

Substances

  • Phosphatidylinositols
  • Nucleotidases
  • 5'-Nucleotidase
  • Type C Phospholipases